| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/09/2003 | WO2001081376A3 Apo-ai/aii peptide derivatives |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001055411A9 Human sulfatases |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030008837 Therapy |
| 01/09/2003 | US20030008815 For diagnosis and therapy of immune related disease in mammals, including humans; tumor therapy |
| 01/09/2003 | US20030008398 Nucleotide sequences coding polypeptide for use in the treatment of autoimmune and inflammatory diseases |
| 01/09/2003 | US20030008391 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008379 Novel 'pseudomonas stutzeri' strain and process for preparation of xylanase |
| 01/09/2003 | US20030008376 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/09/2003 | US20030008367 Isolation and purification of clostridium botulinum toxins |
| 01/09/2003 | US20030008353 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors |
| 01/09/2003 | US20030008352 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008350 14273 receptor, a novel G-protein coupled receptor |
| 01/09/2003 | US20030008349 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/09/2003 | US20030008345 Expression augmenting sequence elements (EASE) for eukaryotic expression systems |
| 01/09/2003 | US20030008334 Protein for use in the diagnosis, prevention and treatment of cancer |
| 01/09/2003 | US20030008330 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cancer and autoimmune disease |
| 01/09/2003 | US20030008321 Antibody for use as tool in immunoassay |
| 01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008291 Protein for use in diagnosis and treatment of cancer |
| 01/09/2003 | US20030008279 Cells for use in the diagnosis and treatment of viral diseases |
| 01/09/2003 | US20030007983 Two-hybrid assay that detects HIV-1 reverse transcriptase dimerization |
| 01/09/2003 | DE20213551U1 New monoclonal antibody specific for procollagenase 3, useful for diagnosing breast cancer, rheumatoid arthritis and osteoarthritis |
| 01/09/2003 | CA2453864A1 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 01/09/2003 | CA2452082A1 Extracellular messengers |
| 01/09/2003 | CA2452058A1 Bispecific antibodies that bind to vegf receptors |
| 01/09/2003 | CA2451955A1 Antibodies to opgl |
| 01/09/2003 | CA2451854A1 Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof |
| 01/09/2003 | CA2451473A1 Process of purification of amyloid fibrils |
| 01/09/2003 | CA2450710A1 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/08/2003 | WO2002012543A2 Two coloured fluorimetric protease assay |
| 01/08/2003 | EP1273918A2 Method of selecting evolved binding members using a native epitope |
| 01/08/2003 | EP1273662A2 Reversible nuclear genetic system for male sterility in transgenic plants |
| 01/08/2003 | EP1273655A1 Process for producing recombinant protein |
| 01/08/2003 | EP1273593A1 Isolation and purification of clostridium botulinum toxins |
| 01/08/2003 | EP1273239A1 Composition comprising partly-hydrolyzed fish gelatin and use thereof. |
| 01/08/2003 | EP1272669A1 High-throughput screening of expressed dna libraries in filamentous fungi |
| 01/08/2003 | EP1272653A2 Methods for ansamitocin production |
| 01/08/2003 | EP1272647A1 Multivalent antibodies and uses therefor |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272636A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272624A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 01/08/2003 | EP1272622A1 Method for modification of proteins by transglutaminase |
| 01/08/2003 | EP1272612A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 01/08/2003 | EP1272609A2 Single chain antibody against mutant p53 |
| 01/08/2003 | EP1272527A2 Anti-d monoclonal antibodies |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272512A2 Immunokine composition and method |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272508A2 Methods for producing recombinant proteins |
| 01/08/2003 | EP1272503A1 DNA MOLECULES ENCODING L-GLUTAMATE-GATED CHLORIDE CHANNELS FROM i RHIPICEPHALUS SANGUINEUS /i |
| 01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
| 01/08/2003 | EP1098665B1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/08/2003 | EP0996727B1 Gene conferring obese phenotype |
| 01/08/2003 | EP0929579B1 Monoclonal antibodies against a human act and serine protease complex |
| 01/08/2003 | EP0817646B1 Methods of treating inflammation and compositions therefor |
| 01/08/2003 | EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 01/08/2003 | CN1390258A Factor IX/factor IXa antibodies and antibody derivatives |
| 01/08/2003 | CN1390233A Antitumor antibodies, proteins, and uses thereof |
| 01/08/2003 | CA2415458A1 Two coloured fluorimetric protease assay |
| 01/07/2003 | US6504082 Ecdysone receptors and methods for their use |
| 01/07/2003 | US6504013 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| 01/07/2003 | US6504011 Recombinantly produced serum albumin is purified in a series of steps, optionally by incubation with an anion-exchange adsorbent, followed by affinity chromatography employing a hydrophobic solid phase and using a water-soluble lipid anion |
| 01/07/2003 | US6504007 GDNF receptor |
| 01/07/2003 | US6503736 Antibodies to crosslinkers and methods for using the same |
| 01/07/2003 | US6503733 Polynucleotides which identify and encode NANCH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NANCH and a method for producing NANCH. Agonists, antibodies |
| 01/07/2003 | US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells |
| 01/07/2003 | US6503728 A nucleic acid comprising a nucleic acid sequence encoding pantropic hNT3 or hNGF having an alanine residue substituted at a position corresponding to D15 in hNT3 or D16 in hNGF, wherein the alanine substitution imparts trkB-binding such |
| 01/07/2003 | US6503702 Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction |
| 01/07/2003 | US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 01/07/2003 | US6503510 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 01/07/2003 | US6503508 Detergents |
| 01/07/2003 | CA2220923C Process of high purity albumin production |
| 01/07/2003 | CA2190373C Yeast strains |
| 01/07/2003 | CA2113363C Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 01/07/2003 | CA2104598C Methods for selection of recombinant host cells expressing high levels of a desired protein |
| 01/07/2003 | CA1341415C Targeted multifunctional proteins |
| 01/06/2003 | CA2392549A1 Acetyl-coa carboxylase subunits |
| 01/03/2003 | WO2003001212A2 A method for diagnosing a person having multiple sclerosis |
| 01/03/2003 | WO2003000930A2 Nucleotide sequences involved in plant disease resistance |
| 01/03/2003 | WO2003000909A2 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 01/03/2003 | WO2003000907A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000842A2 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | WO2003000736A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 01/03/2003 | WO2003000732A2 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 01/03/2003 | WO2003000727A2 Atopy |